Connecting...

W1sizmyilcivc3j2l3d3dy9vbgl2zxivy3vycmvudc9wdwjsawmvchjvzhvjdglvbi9wyxjrlxn0cmvldc1wzw9wbguvaw1hz2vzl2nvbnn1bhrhbnqtymfubmvylwrlzmf1bhqtmgy1nwqwmjg0ntvmnta2ngvlnzkynzdknjkymzeynwyuanbnil0swyjwiiwidgh1bwiilciyntywedqwmcmixv0
W1siziisijiwmtyvmtavmdqvmjevndmvmzcvmtk4l01vbm9wb2x5lwzvcm1hbc1jb2wuanbnil0swyjwiiwidgh1bwiilci2mdb4njawiyjdxq

Monopoly graduated in Law in 2015 and joined Park Street in an admin and resourcing capacity shortly after. She quickly showed a real skill in sourcing and placing a team of high end individuals within the Pharmaceutical sector and due to her success on this project, she has now taken up the role of fully fledged recruitment consultant.

Monopoly now specialises in recruiting within the Pharmaceutical and Healthcare industries, with a particular focus on placing a range of mid to senior level individuals within Clinical Trials, Pharmacovigilance and Drug Safety for a broad range of therapy areas but especially Oncology, Cardiovascular, Respiratory and Neuro-degenerative.

She is currently extending her network to include clinical trial administrators, clinical research associates, clinical project managers, clinical research directors, PV associates and also directors with varied case processing and reporting experience. 

Monopoly also focuses on finding new talent to join Park Street People too.

Monopoly's latest vacancies

  • Principal Investigator/ Senior Research Physician- Birmingham

    Coin£60,000 to £75,000

    • Neurology Research 
    • Phase III studies
    • Career Progression 
    • Innovative Research 
  • Clinical Research Physician - Birmingham

    Coin£50,000 to £60,000

    • Neurology Research
    • Phase III Studies
    • Career Progression
    • Innovative Studies
  • Sub-Investigator-Research Physician Drug Development

    CoinFrom £50,000

    • Leaders in Neurology research in Alzheimer’s disease
    • Chance to join an amazing team with innovative studies
    • Potential and support for progression
    • Use your experience to contribute towards drug development